News

Using rapamycin to rein in an overactive mTOR cell signaling pathway isn’t an effective way to treat fragile X syndrome, a study in mice indicates. It showed that rapamycin does not reverse most behavioral characteristics of the disease, including learning and memory problems, susceptibility to seizure, and hyperactivity. And it made mice’s…

The intellectual disabilities in people with fragile X syndrome may be caused by poor communication between neurons, rather than flaws in the nerve cells, according to research from New York University. A research team there discovered that groups of neurons failed to signal in unison when mice with the…